Speakers of Targeting Mitochondria 2020

Welcome Note & Introduction Remarks
Volkmar Weissig, President of the World Mitochondria Society, Midwestern University, USA

FBXL4 Deficiency leads to increased clearance of Mitochondria
Nils-Göran Larsson, Karolinska Institutet, Sweden

Mitochondria devices: New methods to detect mitochondria dysfunction
Naïg Gueguen,  MitoVasc Institute, Angers University Hospital Center, France

Mitochondrial dysfunction in autism is distinct from mitochondrial disease
Richard E. Frye, Phoenix Children's Hospital, USA

Mitochondria and microbiota dysfunction in COVID-19 pathogenesis
Marvin Edeas, University Paris Descartes, Inserm 1016, Institute Cochin, France

Neurodegeneration and mitochondria
Ming Guo, UCLA David Geffen School of Medicine, USA

Molecular mechanisms of ncRNAs transport into mitochondria: emerging approaches and potential gene therapy applications
Nina Entelis, UNISTRA, France

Long non-coding RNA SAMMSON and beyond: Uncoupling cytosolic and mitochondrial-translation as an effective anti-melanoma strategy
Eleonora Leucci, Laboratory for RNA Cancer Biology, Department of Oncology, KU Leuven, Belgium

Targeting long non-coding mitochondrial RNA for cancer therapy
Veronica Burzio, Universidad Andrés Bello, Fundación Ciencia & Vida, Andes Biotechnologies, Republic of Chile

Round table: Prospective on other mitochondrial gene therapies
moderated by Ivan Tarassov, UNISTRA, Strasbourg, France